http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112021001031-A2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_974e85b63e612107f74e1a6781c4f2ca |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-473 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C309-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C309-29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C309-35 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D221-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
filingDate | 2019-07-22^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52c8064e740bb46ea2e7f32c7a0fe7ba http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b429d77ca029072e8bc18dddfcd06ed http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f68806040977817adcea139bd9d0bba http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0634ad19f06f0694262bae13224c914 |
publicationDate | 2021-04-13^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | BR-112021001031-A2 |
titleOfInvention | COMPOUND, PHARMACEUTICAL COMPOSITION, COSMETIC COMPOSITION, AND, METHODS FOR TREATING OR PREVENTING A DISEASE OR DISORDER, TO PREVENT OR REDUCE THE PROBABILITY OF PREGNANCY, TO TREAT OR PREVENTING THE PREVENTION OF OVERSEAS, TO PREVENT PREVENTION OF OVERSEAS. OF SKIN PIGMENTATION, SKIN PROTECTION AND TO TREAT OR PREVENT CANCER, PREVENT CANCER RECURRENCE OR INHIBIT CANCER PROGRESSION |
abstract | COMPOUND, PHARMACEUTICAL COMPOSITION, COSMETIC COMPOSITION, AND, METHODS FOR TREATING OR PREVENTING A DISEASE OR DISORDER, TO PREVENT OR REDUCE THE PROBABILITY OF PREGNANCY, TO TREAT OR PREVENTING THE PREVENTION OF OVERSEAS, TO PREVENT PREVENTION OF OVERSEAS. OF SKIN PIGMENTATION, SKIN PROTECTION AND TO TREAT OR PREVENT CANCER, PREVENT CANCER RECURRENCE OR INHIBIT CANCER PROGRESSION. The present description provides 1) an enantiomerically purified SRR G-1 compound or a derivative thereof, including specific crystalline forms, salts and crystals that modulate the activity of the estrogen receptor coupled to the G protein, 2) pharmaceutical and cosmetic compositions comprising an SRR Enantiomerically purified G-1 or a derivative thereof and 3) methods for treating or preventing disease states and conditions and cosmetic conditions mediated through these receptors and related methods thereof in humans and animals. |
priorityDate | 2018-07-21^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 1000 of 1063.
Next Page | Last Page |